Pharma

Your Article Summary

See Latest Articles

FDA Issues Complete Response Letter for Corvue
King Pharmaceuticals, 10/22/09

King Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration issued a complete response letter regarding the New Drug Application for CorVue for injection. CorVue is a cardiac pharmacologic stress agent for use as an adjunct in SPECT cardiac imaging intended for use in patients with or at risk for coronary artery disease who are unable to perform a cardiac exercise stress test.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

Gilead and GlaxoSmithKline Announce Agreement to Commercialize Viread(R) for Chronic Hepatitis B in Key Asian Countries
Gilead, 11/25/09

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex Fully Covered Esophageal Stent
Boston Scientific, 11/24/09

AstraZeneca submits US New Drug Application for ticagrelor, an investigational antiplatelet agent
AstraZeneca, 11/23/09

 See all of Drug/Product Approvals

Today in Regulatory Issues...keeping you current

Receive free subspecialty "5-minute updates" via email

Tricare contracts may be re-bid after losing plans protest
American Medical News , 11/25/09

AMA meeting: No flu shot mandate for doctors; hand sanitizer pushed
American Medical News , 11/25/09

GSK Regulatory Update: Avodart
GlaxoSmithKline, 11/24/09

 See all of Regulatory Issues